Alterity Therapeutics Ltd.ASX: ATH

Orphan Designation for PBT434 for treatment of MSA

Jan 31, 2019 at 3:38 AM UTC · Issued by Alterity Therapeutics Ltd.

Alterity Therapeutics Ltd has released a press release.

View Attachment